Ascentage Pharma Group International Financials

Market Capitalization HK$29.55 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE
Forward PE	-27.62
Price to Sales TTM	HK$30.13
Price to Book MRQ	HK$100.24
Enterprise to Revenue	24.79
Enterprise to EBITDA	-81.34

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-12-31
Profit Margin	-41.34%
Operating Margin	-361.23%
Return on Assets TTM	-9.25%
Return on Equity TTM	-235.32%

Income Statement

Revenue TTM	HK$1,073,419,472
Revenue per Share TTM	HK$3.25
Quarterly Revenue Growth	97.90%
Gross Profit TTM	HK$1,041,583,040
EBITDA	HK$-327,140,912
Net Income to Common TTM	HK$-443,786,953
Diluted EPS TTM	HK$-1.47
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	HK$1,386,396,331
Total Cash per Share MRQ	HK$4.06
Total Debt MRQ	HK$
Total Debt to Equity MRQ	608.58
Current Ratio MRQ	1.26
Book Value per Share MRQ	HK$0.85

Cash Flow

Operating Cash Flow TTM	HK$-121,891,372
Levered Free Cash Flow TTM	HK$-88,934,332

6855 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	315,224,993
Float Shares	234,428,883
Avg 10 Volume	5,261,520
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	24.40%
% Held by Institutions	13.22%

Stock Price Summary

Beta	0.78
Fifty Two Week Low	HK$26.05
Fifty Two Week High	HK$86.70
Fifty Two Week Change	67.98%
Day 50 MA	HK$56.41
Day 200 MA	HK$44.37

Dividends and Splits

Forward Annual Dividend Rate	HK$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	HK$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date